Patients with NASH have been enrolled in 3 phase III trials of Saroglitazar, says Zydus Cadila Medical Dialogues Bureau18 July 2019 9:17 AM IST"Patients with NASH have been enrolled in these trials across clinical sites in India and Mexico," Cadila Healthcare, the listed entity of the group,...
Cadila Healthcare gets 14 USFDA observations for Moraiya plant Farhat Nasim4 May 2019 10:00 AM ISTThe US Food and Drug Administration (USFDA) inspected the plant from April 22, 2019 to May 3, 2019, Cadila Healthcare said in a regulatory filing.New...
Biocon, Lupin, Wockhardt, Cadila Healthcare lose Insurance Battle in Delhi High Court Meghna A Singhania3 May 2019 1:50 PM ISTMumbai:In a court setback to many big drugmakers in India, a petition filed by pharma majors including Biocon, Wockhardt, Lupin and Cadila Healthcare...
CDSCO approves Zydus, SIFI pact to launch Intraocular Lenses in India Farhat Nasim30 April 2019 10:15 AM IST"SIFI's innovative IOLs (Intraocular lenses) have been approved by the Indian Central Drugs Standards Control Organisation(CDSCO) (Directorate General...
Prices of 21 New Drugs fixed by NPPA; Details Meghna A Singhania4 April 2019 10:00 AM ISTThe NPPA order is likely to affect drug majors including Torrent Pharma, Alkem Laboratories, Zydus Pharmaceuticals, Cadila Healthcare, Mylan, Cipla,...
NPPA fixes retail price of Emcure pharma's HIV drug Meghna A Singhania17 Feb 2019 9:30 AM ISTNew Delhi: Through a recent notice, the drug price regulator National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of Emcure...
NPPA fixes retail price of 29 drug formulations including BP, Cholesterol, pain medications; Details Farhat Nasim30 Jan 2019 11:32 AM ISTThe NPPA order is likely to affect various drug majors including Lupin, Sun Pharmaceuticals, GlaxoSmithKline and Cadila Pharmaceuticals. New Delhi:...
Cadila gets USFDA nod for generic drug to treat Parkinson Ruby Khatun Khatun15 Dec 2017 4:08 PM ISTNew Delhi: Cadila Healthcare said it has received approval from the US health regulator to market Pramipexole Dihydrochloride extended-release...
Cadila Healthcare Q2 net profit up 32 percent at Rs 503 crore Ruby Khatun Khatun15 Nov 2017 10:00 AM ISTNew Delhi: Drug firm Cadila Healthcare reported a 32.48 percent rise in its consolidated net profit to Rs 503.3 crore for the second quarter ended...
